Indivior
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs over 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Visit www.indivior.com to learn more. Connect with Indivior on LinkedIn by visiting www.linkedin.com/company/indivior.
Domain
indivior.com
Country
United StatesIndustry
Addiction TreatmentEmployees
1001-5000
Last Funding
$400.0M
Founded
2014
No technologies detected yet for this company.
Frequently Asked Questions
What technologies does Indivior use?+
We have not yet detected technologies for Indivior.
What industry is Indivior in?+
Indivior operates in the Addiction Treatment industry.
Where is Indivior based?+
Indivior is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026